Expensify (EXFY) 10-Q 9 May 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 05, 2023
Document Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-41043
Entity Registrant Name	Expensify, Inc.
Entity Incorporation, State	DE
Entity Tax Identification Number	27-0239450
Entity Address, Street	401 SW 5th Ave
Entity Address, City	Portland
Entity Address, State	OR
Entity Address, Postal Zip Code	97204
City Area Code	971
Local Phone Number	365-3939
Title of each class	Class A Common Stock, par value $0.0001 per share
Trading Symbol(s)	EXFY
Name of each exchange on which registered	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001476840
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Common Class A
Document Information
Entity Common Stock, Shares Outstanding		68,507,818
Common Stock, LT10
Document Information
Entity Common Stock, Shares Outstanding		7,335,456
Common Stock, LT50
Document Information
Entity Common Stock, Shares Outstanding		6,975,375

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 111,232	$ 103,787
Accounts receivable, net	15,705	16,448
Settlement assets, net	38,490	35,838
Prepaid expenses	7,411	8,825
Other current assets	21,282	22,217
Total current assets	194,120	187,115
Capitalized software, net	7,581	6,881
Property and equipment, net	14,021	14,492
Lease right-of-use assets	512	745
Deferred tax assets, net	374	344
Other assets	658	664
Total assets	217,266	210,241
Liabilities and stockholders' equity
Accounts payable	2,003	1,059
Accrued expenses and other liabilities	10,770	9,070
Borrowings under line of credit	15,000	15,000
Current portion of long-term debt, net of original issue discount and debt issuance costs	550	551
Lease liabilities, current	443	800
Settlement liabilities	33,144	33,882
Total current liabilities	61,910	60,362
Lease liabilities, non-current	95	0
Other liabilities	1,268	1,204
Long-term debt, net of original issue discount and debt issuance costs	51,297	51,434
Total liabilities	114,570	113,000
Commitments and contingencies (Note 4)
Stockholders' equity:
Preferred stock, par value $0.0001; 10,000,000 shares of preferred stock authorized as of March 31, 2023 and December 31, 2022; no shares of preferred stock issued and outstanding as of March 31, 2023 and December 31, 2022	0	0
Common stock	7	7
Additional paid-in capital	206,207	194,807
Accumulated deficit	(103,518)	(97,573)
Total stockholders' equity	102,696	97,241
Total liabilities and stockholders' equity	$ 217,266	$ 210,241

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock. shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common Class A
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	68,496,251	68,238,245
Common stock, shares outstanding (in shares)	68,496,251	68,238,245
Common Stock, LT10
Common stock, shares authorized (in shares)	24,996,826	24,997,561
Common stock, shares issued (in shares)	7,335,456	7,336,191
Common stock, shares outstanding (in shares)	7,335,456	7,336,191
Common Stock, LT50
Common stock, shares authorized (in shares)	24,999,020	24,999,020
Common stock, shares issued (in shares)	6,974,821	6,854,931
Common stock, shares outstanding (in shares)	6,974,821	6,854,931

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 40,101	$ 40,370
Cost of revenue, net	15,775	14,133
Gross margin	24,326	26,237
Operating expenses:
Research and development	5,418	3,701
General and administrative	12,429	14,006
Sales and marketing	9,183	13,372
Total operating expenses	27,030	31,079
Loss from operations	(2,704)	(4,842)
Interest and other expenses, net	(1,416)	(902)
Loss before income taxes	(4,120)	(5,744)
Provision for income taxes	(1,825)	(1,632)
Net loss , basic	(5,945)	(7,376)
Net loss , diluted	$ (5,945)	$ (7,376)
Net loss per share:
Basic (in dollars per share)	$ (0.07)	$ (0.09)
Diluted (in dollars per share)	$ (0.07)	$ (0.09)
Weighted average shares of common stock used to compute net loss per share:
Basic (in shares)	81,768,429	80,147,208
Diluted (in shares)	81,768,429	80,147,208

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Preferred stock Preferred stock	Common stock	Additional paid-in capital	Accumulated deficit
Beginning balance at Dec. 31, 2021		$ 0
Beginning balance (in shares) at Dec. 31, 2021		0
Ending balance at Mar. 31, 2022		$ 0
Ending balance (in shares) at Mar. 31, 2022		0
Beginning balance at Dec. 31, 2021	$ 76,615		$ 6	$ 142,515	$ (65,906)
Beginning balance (in shares) at Dec. 31, 2021			81,400,860
Increase (Decrease) in Stockholders' Equity
Issuance of common stock on exercise of stock options	252			252
Issuance of common stock on exercise of stock options (in shares)			205,730
Vesting of early exercised stock options	295			295
Issuance of restricted stock units	18			18
Issuance of restricted stock units (in shares)			2,733
Repurchases of early exercised stock options	(4)			(4)
Repurchases of early exercised stock options (in shares)			(2,330)
Stock-based compensation	14,667			14,667
Net loss	(7,376)				(7,376)
Ending balance at Mar. 31, 2022	84,467		$ 6	157,743	(73,282)
Ending balance (in shares) at Mar. 31, 2022			81,606,993
Beginning balance at Dec. 31, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2022		0
Ending balance at Mar. 31, 2023		$ 0
Ending balance (in shares) at Mar. 31, 2023		0
Beginning balance at Dec. 31, 2022	97,241		$ 7	194,807	(97,573)
Beginning balance (in shares) at Dec. 31, 2022			82,429,367
Increase (Decrease) in Stockholders' Equity
Issuance of common stock on exercise of stock options	$ 66			66
Issuance of common stock on exercise of stock options (in shares)	50,994		50,994
Vesting of early exercised stock options	$ 216			216
Issuance of restricted stock units	31			31
Issuance of restricted stock units (in shares)			1,548
Repurchases of early exercised stock options	(7)			(7)
Repurchases of early exercised stock options (in shares)			(735)
Issuance of common stock under Matching Plan	1,099			1,099
Issuance of common stock under Matching Plan (in shares)			163,417
Issuance of common stock in connection with restricted stock units vesting (in shares)			245,313
Shares withheld from common stock issued to pay employee payroll taxes	(666)			(666)
Shares withheld from common stock issued to pay employee payroll taxes (in shares)			(83,376)
Stock-based compensation	10,661			10,661
Net loss	(5,945)				(5,945)
Ending balance at Mar. 31, 2023	$ 102,696		$ 7	$ 206,207	$ (103,518)
Ending balance (in shares) at Mar. 31, 2023			82,806,528

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (5,945)	$ (7,376)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,413	1,167
Reduction of operating lease right-of-use assets	181	185
Loss on impairment, receivables and sale or disposal of equipment	146	231
Stock based compensation expense including capitalized amount	10,004	14,667
Amortization of original issue discount and debt issuance costs	11	10
Deferred tax assets	(30)	0
Changes in assets and liabilities:
Accounts receivable, net	707	(482)
Settlement assets, net	(2,683)	(5,689)
Prepaid expenses	1,414	377
Related party loan receivable	0	14
Other current assets	406	(224)
Other assets	8	80
Accounts payable	944	(2,316)
Accrued expenses and other liabilities	1,947	(2,635)
Operating lease liabilities	(206)	(6)
Settlement liabilities	(738)	12,433
Other liabilities	63	787
Net cash provided by operating activities	7,642	11,223
Cash flows from investing activities:
Purchases of property and equipment	(28)	(179)
Software development costs	(870)	(494)
Net cash used in investing activities	(898)	(673)
Cash flows from financing activities:
Principal payments of finance leases	(201)	(197)
Principal payments of term loan	(150)	(146)
Vesting of early exercised stock options	0	295
Issuance of restricted stock units	0	18
Repurchases of early exercised stock options	(7)	(4)
Proceeds from common stock purchased under Matching Plan	1,099	0
Proceeds from issuance of common stock on exercise of stock options	66	252
Payments for employee taxes withheld from stock-based awards	(666)	0
Net cash provided by financing activities	141	218
Net increase in cash and cash equivalents and restricted cash	6,885	10,768
Cash and cash equivalents and restricted cash, beginning of period	147,710	125,315
Cash and cash equivalents and restricted cash, end of period	154,595	136,083
Supplemental disclosure of cash flow information:
Cash paid for interest	1,409	267
Cash paid for income taxes	351	284
Noncash investing and financing items:
Stock-based compensation capitalized as software development costs	657	287
Right-of-use assets acquired through operating leases	145	0
Reconciliation of cash and cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	111,232	101,101
Restricted cash included in other current assets	19,013	9,973
Restricted cash included in other assets	0	46
Restricted cash included in settlement assets, net	24,350	24,963
Total cash, cash equivalents and restricted cash	$ 154,595	$ 136,083

GENERAL INFORMATION

GENERAL INFORMATION	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
GENERAL INFORMATION	GENERAL INFORMATION Description of the Business Expensify, Inc. ("Expensify") was incorporated in Delaware on April 29, 2009. Expensify offers a comprehensive expense management platform that integrates with a variety of third-party accounting applications, including QuickBooks Desktop, QuickBooks Online, Xero, NetSuite, Intacct, Sage, Microsoft Dynamics, MYOB and others. Expensify's product simplifies the way that employees and vendors manage and submit expense receipts and bills and provides efficiencies to companies for the payment of those bills. Expensify delivers its services over the internet to corporations and individuals under license arrangements and offers unique pricing options for small and midsized businesses and enterprises on a per-active-member basis. Expensify also offers an Expensify charge card (the "Expensify Card"), which is primarily distributed to corporate customers in the United States ("U.S.") that subsequently distribute the card to their employees for business use. The Expensify Card allows customers to have real-time control over their employees' spending and compliance with spending limits in addition to eReceipt reporting on purchases. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Expensify and its wholly-owned subsidiaries (the "Company") and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim reporting in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report"). All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments that are necessary for the fair presentation of the Company's financial position, results of operations, equity, and cash flows for the periods presented. Results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or for any other future annual or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets, income taxes, capitalization of internal-use software costs, and stock-based compensation. Updates to Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2 of the 2022 Annual Report. Since the date of the 2022 Annual Report, there have been no material changes to the Company's significant accounting policies, including the status of recent accounting pronouncements adopted, other than those detailed below. Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instrume nts - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments , with subsequent ASUs issued that clarify the guidance (collectively, "Topic 326"). Topic 326 requires an entity to utilize a new impairment model known as the current expected credit loss ("CECL") model to estimate its “lifetime expected credit losses" using a forward-looking approach and to record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. Topic 326 also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. As a result of no longer qualifying as an emerging growth company as of December 31, 2022 , the Company was required to adopt Topic 326 retroactive to January 1, 2022. T he Company was not required to amend quarterly filings issued subsequent to January 1, 2022 in which the Company filed under the legacy credit loss guidance of ASC Topic 310. As such, the 2022 Annual Report was the first period under which the Company reported credit loss estimates in accordance with Topic 326. The adoption of Topic 326 did not have a material impact on the Company's financial position or results of operations as of and for the three months ended March 31, 2022.

REVENUE AND CERTAIN STATEMENT O

REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS	3 Months Ended
	Mar. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]
REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS	REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS Revenue by geographic region, based on user address, was as follows (in thousands): Three Months Ended March 31, 2023 2022 United States $ 36,635 $ 36,518 All other locations 3,466 3,852 Total revenue $ 40,101 $ 40,370 No individual customer represented more than 10% of the Company’s total revenue during the three months ended March 31, 2023 and 2022. Cashback Rewards The Company offers a cashback rewards program to all customers based on volume of Expensify Card transactions and Software as a Service ("SaaS") subscription tier. Cashback rewards are earned on a monthly basis and paid out the following month. The Company considers the cashback payments to customers as consideration payable to a customer and it is recorded as contra revenue within Revenue on the Condensed Consolidated Statements of Operations. Cashback rewards for the three months ended March 31, 2023 and 2022 was $1.2 million and $0.5 million, respectively. Consideration From a Vendor, Net The Company receives consideration from a vendor for monetizing Expensify Card activities. This consideration, net of credit card processing fees paid to the vendor, is included as a reduction to Cost of revenue, net within the Condensed Consolidated Statements of Operations. Consideration from a vendor, net for the three months ended March 31, 2023 and 2022 was $2.1 million and $1.1 million, respectively.

CERTAIN BALANCE SHEET COMPONENT

CERTAIN BALANCE SHEET COMPONENTS	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
CERTAIN BALANCE SHEET COMPONENTS	CERTAIN BALANCE SHEET COMPONENTS Other Current Assets Other current assets consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Expensify Card posted collateral for funds held for customers $ 8,645 $ 11,509 Expensify.org restricted cash 5,636 5,518 Cash in transit for funds held for customers 4,603 2,361 Income tax receivable 2,124 2,471 Expensify Payments LLC restricted cash 100 102 Matching Plan escrow and other restricted cash 29 52 Other 145 204 Other current assets $ 21,282 $ 22,217 Capitalized Software, Net Capitalized software, net consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Capitalized software development costs $ 15,349 $ 14,052 Less: accumulated amortization (7,768) (7,171) Capitalized software, net $ 7,581 $ 6,881 Amortization expense related to capitalized software development costs is recorded in Cost of revenue, net on the Condensed Consolidated Statements of Operations. Amortization expense was $0.7 million for the three months ended March 31, 2023 and 2022. Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Computers and equipment $ 178 $ 178 Furniture and fixtures 1,716 1,698 Leasehold improvements 6,957 6,948 Commercial building 6,493 6,493 Land 4,151 4,151 Construction in progress 2,551 2,551 Total property and equipment 22,046 22,019 Less: accumulated depreciation (8,025) (7,527) Property and equipment, net $ 14,021 $ 14,492 Depreciation expense related to property and equipment is recorded in General and administrative and Sales and marketing on the Condensed Consolidated Statements of Operations. Depreciation expense related to property and equipment for the three months ended March 31, 2023 and 2022 was $0.5 million. Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Sales, payroll and other taxes payable $ 3,521 $ 2,721 Professional fees 1,936 1,473 Interest payable 1,407 1,318 Restricted common stock liability for early stock option exercises 1,067 1,283 Partner payouts and advertising fees 809 669 Cashback rewards 586 223 Accrued expense reports 264 291 Matching Plan payroll liability 192 195 Credit card processing fees 170 22 Hosting and license fees 84 75 Other 734 800 Accrued expenses and other liabilities $ 10,770 $ 9,070

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Finance and Operating Lease Arrangements During the three months ended March 31, 2023, the Company entered into two operating lease agreements, one of which has not commenced as of period end. The components of lease cost reflected in the Condensed Consolidated Statements of Operations were as follows (in thousands): Three Months Ended March 31, 2023 2022 Finance lease cost: Amortization of ROU assets $ 198 $ 198 Interest on lease liabilities 3 7 Total finance lease cost 201 205 Operating lease cost 186 185 Total lease cost $ 387 $ 390 Other information related to leases was as follows (in thousands, except as noted within): As of March 31, As of December 31, 2023 2022 Finance lease ROU asset (included within Lease right-of-use assets) $ 263 $ 461 Operating lease ROU asset (included within Lease right-of-use assets) $ 249 $ 284 Weighted average remaining lease term (in years): Finance leases 0.33 0.58 Operating leases 1.55 0.42 Weighted average discount rate: Finance leases 2.50 % 2.50 % Operating leases 7.30 % 5.30 % Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ (210) $ (192) Operating cash flows from finance leases $ (3) $ (7) Financing cash flows from finance leases $ (201) $ (197) Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands): Finance leases Operating leases For the year ending: Remainder of 2023 $ 272 $ 175 2024 — 56 2025 — 58 2026 — — 2027 — — Thereafter — — Total future lease payments 272 289 Less: imputed interest (1) (22) Less: lease liabilities, current (271) (172) Lease liabilities, non-current $ — $ (95) The Company has entered into an operating lease that has not commenced at period end. As of March 31, 2023 the future minimum lease payments on this lease approximated $2.6 million. On April 20, 2023 the Company entered into an amendment to extend the operating lease for the San Francisco office for 11 years. The future minimum lease payments of the extended term are expected to be approximately $6.9 million. Amortizing Term Mortgage In August 2019, the Company entered into an $8.3 million amortizing term mortgage agreement with Canadian Imperial Bank of Commerce ("CIBC") for the Company's commercial building located in Portland, Oregon. The agreement requires principal and interest payments be made each month over a 30-year period. Interest accrues at a fixed rate of 5.00% per year until August 2024, at which point the interest rate changes to the Wall Street Journal Pri me Rate less 0.25% for the remaining term of the mortgage. The borrowings are secured by the building. The outstanding balance of the amortizing term mortgage was $7.8 million a s of March 31, 2023 and December 31, 2022. 2021 Amended Term Loan In September 2021, the Company amended and restated its loan and security agreement with CIBC ("2021 Amended Term Loan") to refinance the existing non-amortizing and amortizing term loans, establish a single term loan of up to $75.0 million, consisting of a $45.0 million initial term loan effective immediately with an option to enter into an additional $30.0 million delayed term loan, and increase the monthly revolving line of credit to $25.0 million. The option for the delayed term loan expired in March 2023. The term loan and revolving line of credit mature in September 2026 and September 2024, respectively. Approximately $23.5 million of the loan proceeds were used to immediately repay the remaining balances under the amortizing and non-amortizing term loans at the time of the amendment, as well as commitment fees and other debt issuance costs associated with the amendment. The remaining proceeds from the initial term loan were utilized to fund the Company's normal business operations. Under the 2021 Amended Term Loan, the initial term loan of $45.0 million is payable over a 60-month period with principal and accrued interest payments due each quarter, commencing on September 30, 2021. The 2021 Amended Term Loan amortizes in equal quarterly installments of $0.1 million through September 30, 2024, $0.2 million beginning October 1, 2024 and $0.6 million beginning October 1, 2025, with any remaining principal balance due and payable on maturity. The amounts borrowed bear interest at the bank’s reference rate plus 2.25% (10.25% as of March 31, 2023 ) beginning on September 30, 2021 and continuing on a quarterly basis through maturity of the term loan. The borrowings are secured by substantially all the Company’s assets. As of March 31, 2023 and December 31, 2022, the outstanding balance of the 2021 Amended Term Loan was $44.3 million and $44.5 million, respectively. Monthly Revolving Line of Credit The line of credit agreement, as amended with the 2021 Amended Term Loan, provides borrowings up to $25.0 million. Borrowings under the line of credit bear interest at CIBC’s reference rate plus 1.00% (9.00% as of March 31, 2023) and are secured by substantially all of the Company’s assets. As of March 31, 2023 and December 31, 2022 , there were $15.0 million of borrowings under the line of credit and $10.0 million of capacity available for additional borrowings. In connection with the amortizing term mortgage and the 2021 Amended Term Loan, the Company recorded an immaterial amount of debt issuance costs and the 2021 Amended Term Loan was subject to an original issue discount. These amounts are being amortized to interest expense over the term of the respective agreements using the effective interest method. As of March 31, 2023 and December 31, 2022 , unamortized original issue discount and debt issuance costs were $0.3 million. Future aggregate annual principal payments on long-term debt as of March 31, 2023 is expected to be as follows (in thousands): For the year ending: Remainder of 2023 $ 447 2024 715 2025 1,397 2026 42,355 2027 176 Thereafter 7,015 Total principal payments 52,105 Less: unamortized original issue discount and debt issuance costs (258) Less: current portion, net of unamortized original issue discount and debt issuance costs (550) Long-term debt, net of unamortized original issue discount and debt issuance costs $ 51,297 As of March 31, 2023, the Company was not in compliance with all debt covenants, specifically the covenant restricting the amount of repurchases of common stock, which includes RSU net share settlements, and the covenant related to the requirement to maintain all deposit, operating and collateral accounts with CIBC with certain exceptions during the period. A waiver was obtained from CIBC. The Company does not believe non-compliance with this covenant had any material impact on the Company or its operations. Defined Contribution Plans The Company sponsors a U.S. 401(k) defined contribution plan for all eligible employees who elect to participate. The Company is permitted to make discretionary profit sharing and 401(k) matching contributions as defined in the plan and as approved by the Board of Directors. Effective January 1, 2018, the Company matches up to 4.50% of each participant’s eligible compensation. The Company’s actual contribution may be reduced by certain available forfeitures, if any, during the plan year. No discretionary profit-sharing contributions were made during the three months ended March 31, 2023 and 2022 . The Company’s 401(k) matching contributions for the three months ended March 31, 2023 and 2022 were $0.3 million and $0.2 million , respectively. Legal From time to time in the normal course of business, the Company may be involved in claims, proceedings and litigation. In the case of any litigation, the Company records a provision for a liability when management believes that it is both probable that a liability has been incurred, and the amount of the loss can be reasonably estimated. The Company reviews such provisions at least quarterly and adjusts such provisions to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case.

STOCK INCENTIVE PLANS

STOCK INCENTIVE PLANS	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
STOCK INCENTIVE PLANS	STOCK INCENTIVE PLANS 2009 and 2019 Stock Plans In 2009, the Board of Directors approved the 2009 Stock Plan ("2009 Stock Plan"). As amended in 2015, the 2009 Stock Plan permitted the Company to grant up to 16,495,150 shares of common stock. In January 2018, the Company increased the number of shares of common stock reserved under the 2009 Stock Plan by 535,130 shares, from 16,495,150 shares to 17,030,280. In April 2019, the Board of Directors approved the adoption of the 2019 Stock Plan ("2019 Stock Plan", and together with the 2009 Stock Plan, "Stock Plans"). The 2019 Stock Plan permitted the Company to grant up to 8,173,970 additional shares, increasing the overall common stock reserved for grant under the Stock Plans to 25,204,250 shares. In September 2021, the Board of Directors approved the grant of 8,679,380 restricted stock units under the 2019 Stock Plan, covering an aggregate of 4,339,690 shares of each of Class A and LT50 common stock effective immediately prior to the effectiveness of the Company's IPO Registration Statement on Form S-1 ("IPO Registration Statement") on November 9, 2021. On November 9, 2021, the Board of Directors amended and restated the 2019 Stock Plan to, among other things, increase the common stock reserved for issuance under the 2019 Stock Plan to an aggregate of 16,856,770 shares of Class A and LT50 common stock. Following the completion of the initial public offering of the Company’s Class A common stock ("IPO"), the Company did not and does not intend to make any further grants under the Stock Plans. However, the Stock Plans will continue to govern the terms and conditions of the outstanding awards granted under the Stock Plans. Upon the expiration, forfeiture, cancellation, withholding of shares upon exercise or settlement of an award to satisfy the exercise price or tax withholding, or repurchase of any shares of Class A common stock underlying outstanding stock-based awards granted under the 2009 Stock Plan or of Class A or LT50 common stock underlying outstanding stock-based awards granted under the 2019 Stock Plan, an equal number of shares of Class A common stock will become available for grant under the 2021 Incentive Award Plan ("2021 Plan") and the Company's 2021 Stock Purchase and Matching Plan ("Matching Plan" and together with the 2021 Plan, "2021 Incentive Plans"). 2021 Incentive Plans In November 2021, the Board of Directors adopted, and its stockholders approved, the 2021 Incentive Plans, which both became effective immediately before the effectiveness of the IPO Registration Statement and use a combined share reserve. Under the 2021 Incentive Plans, 11,676,932 shares of Class A common stock were initially reserved for issuance pursuant to a variety of stock-based awards, including incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock awards, restricted stock units ("RSUs"), and other forms of equity and cash compensation under the 2021 Plan and purchase rights and matching awards under the Matching Plan. The number of shares initially reserved for issuance or transfer pursuant to awards under the 2021 Incentive Plans will be increased upon the expiration, forfeiture, cancellation, withholding of shares upon exercise or settlement of an award to satisfy the exercise price or tax withholding, or repurchase of any shares of Class A common stock underlying outstanding stock-based awards granted under the 2009 Stock Plan or of Class A or LT50 common stock underlying outstanding stock-based awards granted under the 2019 Stock Plan. The number of shares of Class A common stock reserved for issuance under the 2021 Incentive Plans as of March 31, 2023 and December 31, 2022 was 22,282,735 shares and 17,336,973 shares, respectively. The number of shares will automatically increase each subsequent January 1 through January 1, 2031, by the lesser of (A) 6% of the aggregate number of shares of all classes of common stock outstanding on the immediately preceding calendar year, or (B) such lesser number of shares as determined by the Company’s board of directors or compensation committee; provided, however, that no more than 87,576,990 shares of Class A common stock may be issued upon the exercise of incentive stock options. Matching Plan The Matching Plan operates using consecutive three-month offering periods that commenced on March 15, 2022. Employees, consultants and directors (collectively, "Service Providers") of the Company can participate in the Matching Plan by electing to contribute compensation through payroll deductions or from fee payments or may be granted discretionary awards under the Matching Plan. On the last day of the offering period the contributions made during the offering period are used to purchase shares of Class A common stock. The price at which Class A common stock is purchased under the Matching Plan equals the average of the high and low trading price of a share of Class A common stock as of the last trading day of the offering period. At the end of each offering period, the Company may provide a discretionary match up to 1/10 of a share of Class A common stock for each share of Class A common stock purchased by or issued to a service provider under the Matching Plan that is retained through the end of the applicable offering period. No fractional shares will be issued by the Company. The Company will round to the nearest full share for shares purchased by a service provider as well as any matched shares issued to a service provider under the Matching Plan. The match rate applicable to each offering period shall be limited to 1.50% of the shares of any class of capital stock outstanding as of the exercise date applicable to such offering period. The Company estimates the fair value of matched shares provided under the Matching Plan using the Black-Scholes option-pricing model on the date of grant. The Company recognizes stock-based compensation expense related to the matched shares pursuant to its Matching Plan on a straight-line basis over the applicable three-month offering period. Service Providers who participated in the Matching Plan for the offering period ended March 14, 2023 purchased a total of 147,319 Class A common shares, based on a purchase price of $7.46, resulting in gross cash proceeds to the Company of $1.1 million. For the offering period ended March 14, 2023, the Company elected to match each share of Class A common stock purchased by or issued under the Matching Plan with 1/20 of a share of Class A common stock. During the three months ended March 31, 2023, the Company granted 16,098 shares of Class A common stock under the Matching Plan. Restricted Stock Units On September 24, 2021, under the 2019 Stock Plan, the Company approved the grant of Class A and LT50 common stock RSUs to Service Providers effective November 9, 2021, the date the Company amended its Certificate of Incorporation, to include, among other things, LT50 common stock. RSUs granted to Service Providers on November 9, 2021 that were approved in September 2021 vest upon the satisfaction of both a performance and service condition. The performance condition was satisfied immediately prior to the effectiveness of the IPO Registration Statement. The service condition is satisfied over eight years with 1/8 of the grant vesting on September 15, 2022 and quarterly vesting of 1/32 of the grant every December 15, March 15, June 15 and September 15 (each, a "Specified Quarterly Date") thereafter until fully vested, in each case subject to continued service to the Company. All RSUs granted to Service Providers after the IPO, under the 2021 Plan, have a service condition only, which is satisfied over eight years from the vesting commencement date corresponding to one of the Specified Quarterly Dates nearest the date of grant, with 1/8 of each grant vesting on the first anniversary of the vesting commencement date and 1/32 of each grant vesting in equal quarterly installments thereafter until fully vested, in each case, subject to continued service to the Company. Pursuant to the Company's Non-Employee Director Compensation Program, which was adopted under the 2021 Incentive Plans, the Company granted no Class A common stock RSUs for the three months ended March 31, 2023. A total of 2,313 Class A common RSUs vested during the three months ended March 31, 2023 related to previously-granted RSU awards as the quarterly service conditions were satisfied. During the three months ended March 31, 2023, RSU activity for Service Providers and non-employee directors was as follows: Class A Common Stock LT50 Common Stock Weighted average grant date fair value per share Outstanding at December 31, 2022 3,379,657 3,304,643 $ 33.88 RSUs vested (123,549) (119,890) $ 33.35 RSUs cancelled/forfeited/expired (53,253) (53,253) $ 40.91 Outstanding at March 31, 2023 3,202,855 3,131,500 $ 33.88 As of March 31, 2023 , there was $190.4 million of unamortized stock-based compensation cost related to unvested RSUs, which is expected to be recognized over the remaining weighted average life of 6.03 years. As of December 31, 2022 , there was $204.2 million of unamortized stock-based compensation cost related to unvested RSUs, which was expected to be recognized over the remaining weighted average life of 6.23 years . Stock Options The Stock Plans and the 2021 Plan provide for the grant of incentive and nonstatutory stock options to employees, non-employee directors and consultants of the Company. Under the Stock Plans and the 2021 Plan, the exercise price of incentive stock options must be equal to at least 110% of the fair market value of the common stock on the grant date for a “ten-percent holder” or 100% of the fair market value of the common stock on the grant date for any other participant. The exercise price of nonstatutory options granted must be equal to at least 100% of the fair market value of the Company’s common stock on the date of grant. The Company has only granted options under the Stock Plans. Options typically vest over four years and are exercisable at any time after the grant date, provided that Service Providers exercising unvested options receive restricted common stock that is subject to repurchase at the original exercise price upon termination of service. The repurchase right lapses in accordance with the vesting schedule of the exercised option . Early exercises of options prior to vesting are not deemed to be substantive exercises for accounting purposes and accordingly, amounts received for early exercises of unvested options are recorded as a liability. These repurchase terms are considered to be a forfeiture provision and do not result in variable accounting. There was an immaterial amount of exercised restricted common stock repurchased during the three months ended March 31, 2023 and 2022. As of March 31, 2023 and December 31, 2022, there were 697,275 and 813,311 shares subject to repurchase, respectively, related to unvested stock options that had been early exercised . As of March 31, 2023 and December 31, 2022, the Company recorded a liability related to shares subject to repurchase of $1.1 million and $1.3 million, respectively , which is included within Accrued expenses and other liabilities in the accompanying Condensed Consolidated Balance Sheets . These amounts are reclassified to Common stock and Additional paid-in capital as the underlying shares vest. A summary of the Company's stock option activity was as follows: Shares Weighted average exercise price per share Weighted average Outstanding at December 31, 2022 6,301,650 $ 1.67 5.20 Options exercised (50,994) $ 1.28 Options cancelled/forfeited/expired (29,295) $ 2.69 Outstanding at March 31, 2023 6,221,361 $ 1.67 4.92 Exercisable at March 31, 2023 6,071,111 $ 1.50 4.88 The to tal pretax intrinsic value of options exercised during the three months ended March 31, 2023 and 2022 was $0.4 million and $5.2 million, respectively . The total pretax intrinsic value of options outstanding at March 31, 2023 and December 31, 2022 was $41.3 million and $46.0 million , respectively. The intrinsic value is the difference between the estimated fair market value of the Company’s common stock at the date of exercise and the exercise price for in-the-money options. No options were granted during the three months ended March 31, 2023 and 2022 . As of March 31, 2023 , there was $7.2 million of unrecognized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 1.09 years. As of December 31, 2022 , there was $8.1 million of unrecognized stock-based compensation cost related to unvested stock options, which was expected to be recognized over a weighted average period of 1.21 years. Cash received from option exercises and purchases of shares under the Stock Plans for the three months ended March 31, 2023 and 2022 was $0.1 million and $0.3 million, re spectively. Stock-Based Compensation The following table summarizes the stock-based compensation expense recognized for options granted under the 2009 Stock Plan, options and RSUs granted under the 2019 Stock Plan, RSUs granted under the 2021 Plan and matching shares issued under the Matching Plan (in thousands): Three Months Ended March 31, 2023 2022 Stock options $ 900 $ 1,006 Matching shares 249 2 Restricted stock units 9,512 13,659 Stock-based compensation $ 10,661 $ 14,667 Stock-based compensation expense is allocated based on the cost center to which the award holder spent time during the reported periods. Stock-based compensation expense is included in the following components of expenses on the accompanying Condensed Consolidated Statements of Operations (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue, net $ 3,306 $ 4,908 Research and development 2,206 2,708 General and administrative 2,644 4,975 Sales and marketing 1,848 2,076 Stock-based compensation expense $ 10,004 $ 14,667

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES For the three months ended March 31, 2023, the Company prepared its interim tax provision by applying a year-to-date effective tax rate, which the Company believes results in the best estimate of the annual effective tax rate. For the three months ended March 31, 2023 and 2022, the Company recorded a provision for income taxes of $1.8 million and $1.6 million, respectively, which resulted in effective tax rates of (44.3)% and (28.4)%, respectively. The principal reasons for the difference between the statutory rate and the effective rate for 2023 were primarily due to non-deductible stock-based compensation and the change in the valuation allowance. The principal reason for the difference between the statutory rate and the effective rate for 2022 was due to the change in valuation allowance. The Company follows the provisions of Accounting Standards Codification ("ASC") 740-10, Accounting for Uncertainty in Income Taxes . ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of uncertain tax positions that have been taken or expected to be taken on a tax return. As of March 31, 2023 and December 31, 2022, the Company recorded an uncertain tax position liability, inclusive of interest and penalties, of $1.3 million and $1.2 million respectively, within Other liabilities on the Condensed Consolidated Balance Sheets. This liability includes an immaterial amount of interest and penalties as of March 31, 2023 and no interest and penalties as of December 31, 2022. The Company is subject to income taxes in U.S. federal and various state, local and foreign jurisdictions. The Company's federal and state returns for the tax years ended from December 2018 to December 2021 remain open to examination.

NET LOSS PER SHARE

NET LOSS PER SHARE	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NET LOSS PER SHARE The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended March 31, 2023 2022 Numerator Net loss, basic and diluted $ (5,945) $ (7,376) Denominator Weighted average shares of common stock used to compute net loss per share, basic and diluted 81,768,429 80,147,208 Net loss per share, basic and diluted $ (0.07) $ (0.09) The rights, including the liquidation and dividend rights, of the holders of Class A, LT10 and LT50 common stock are identical, except with respect to voting, conversion and transfer rights. Each share of Class A common stock is entitled to one vote per share, each share of LT10 common stock is entitled to 10 votes per share and each share of LT50 common stock is entitled to 50 votes per share. Each share of LT10 and LT50 common stock is convertible into one share of Class A common stock voluntarily at the option of the holder after the satisfaction of certain requirements, which includes a 10-month notice period for LT10 common stock and a 50-month notice period for LT50 common stock to convert to Class A common stock, or automatically upon certain events. The Class A common stock has no conversion rights. As the liquidation and dividend rights are identical for Class A, LT10 and LT50 common stock, the undistributed earnings are allocated on a proportional basis based on the number of weighted average shares within each class of common stock during the period and the resulting net loss per share attributable to common stockholders will be the same for the Class A, LT10 and LT50 common stock on an individual or combined basis. The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: Three Months Ended March 31, 2023 2022 Weighted average stock options 4,329,958 6,067,912 Matching shares 7,678 39,756 Total 4,337,636 6,107,668

EQUITY

EQUITY	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
EQUITY	EQUITYOn May 10, 2022, the Executive Committee of the Board of Directors approved a share repurchase program with authorization to purchase up to $50.0 million of shares of Class A common stock ("2022 Share Repurchase Program"). The Company may repurchase shares from time to time through open market purchases, in privately negotiated transactions or by other means, including the use of trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934 ("Exchange Act"), in accordance with applicable securities laws and other restrictions. The actual timing, manner, price and total amount of future repurchases will depend on a variety of factors, including business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, restrictions under the terms of loan agreements and other considerations. The 2022 Share Repurchase Program does not obligate the Company to acquire any particular amount of Class A common stock, and the program may be suspended or terminated at any time by the Company at its discretion without prior notice. During the three months ended March 31, 2023, the Company did not repurchase any shares of Class A common stock under the 2022 Share Repurchase Program.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS During the three months ended March 31, 2023 and 2022, Expensify, Inc. contributed $0.1 million and $0.9 million, respectively, to its wholly-owned subsidiary, Expensify.org, a nonprofit benefit organization established by the Company. There were immaterial commitments from Expensify, Inc. that remained open for contribution as of March 31, 2023 and December 31, 2022 .

GENERAL INFORMATION (Policies)

GENERAL INFORMATION (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Expensify and its wholly-owned subsidiaries (the "Company") and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim reporting in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report"). All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments that are necessary for the fair presentation of the Company's financial position, results of operations, equity, and cash flows for the periods presented.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets, income taxes, capitalization of internal-use software costs, and stock-based compensation.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instrume nts - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments , with subsequent ASUs issued that clarify the guidance (collectively, "Topic 326"). Topic 326 requires an entity to utilize a new impairment model known as the current expected credit loss ("CECL") model to estimate its “lifetime expected credit losses" using a forward-looking approach and to record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. Topic 326 also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. As a result of no longer qualifying as an emerging growth company as of December 31, 2022 , the Company was required to adopt Topic 326 retroactive to January 1, 2022. T he Company was not required to amend quarterly filings issued subsequent to January 1, 2022 in which the Company filed under the legacy credit loss guidance of ASC Topic 310. As such, the 2022 Annual Report was the first period under which the Company reported credit loss estimates in accordance with Topic 326. The adoption of Topic 326 did not have a material impact on the Company's financial position or results of operations as of and for the three months ended March 31, 2022.

REVENUE AND CERTAIN STATEMENT_2

REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]
Schedule of Revenue from Geographic Areas	Revenue by geographic region, based on user address, was as follows (in thousands): Three Months Ended March 31, 2023 2022 United States $ 36,635 $ 36,518 All other locations 3,466 3,852 Total revenue $ 40,101 $ 40,370

CERTAIN BALANCE SHEET COMPONE_2

CERTAIN BALANCE SHEET COMPONENTS (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Current Assets	Other current assets consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Expensify Card posted collateral for funds held for customers $ 8,645 $ 11,509 Expensify.org restricted cash 5,636 5,518 Cash in transit for funds held for customers 4,603 2,361 Income tax receivable 2,124 2,471 Expensify Payments LLC restricted cash 100 102 Matching Plan escrow and other restricted cash 29 52 Other 145 204 Other current assets $ 21,282 $ 22,217
Schedule of Capitalized Software, Net	Capitalized software, net consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Capitalized software development costs $ 15,349 $ 14,052 Less: accumulated amortization (7,768) (7,171) Capitalized software, net $ 7,581 $ 6,881
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Computers and equipment $ 178 $ 178 Furniture and fixtures 1,716 1,698 Leasehold improvements 6,957 6,948 Commercial building 6,493 6,493 Land 4,151 4,151 Construction in progress 2,551 2,551 Total property and equipment 22,046 22,019 Less: accumulated depreciation (8,025) (7,527) Property and equipment, net $ 14,021 $ 14,492
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): As of March 31, As of December 31, 2023 2022 Sales, payroll and other taxes payable $ 3,521 $ 2,721 Professional fees 1,936 1,473 Interest payable 1,407 1,318 Restricted common stock liability for early stock option exercises 1,067 1,283 Partner payouts and advertising fees 809 669 Cashback rewards 586 223 Accrued expense reports 264 291 Matching Plan payroll liability 192 195 Credit card processing fees 170 22 Hosting and license fees 84 75 Other 734 800 Accrued expenses and other liabilities $ 10,770 $ 9,070

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Lease Cost	The components of lease cost reflected in the Condensed Consolidated Statements of Operations were as follows (in thousands): Three Months Ended March 31, 2023 2022 Finance lease cost: Amortization of ROU assets $ 198 $ 198 Interest on lease liabilities 3 7 Total finance lease cost 201 205 Operating lease cost 186 185 Total lease cost $ 387 $ 390 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ (210) $ (192) Operating cash flows from finance leases $ (3) $ (7) Financing cash flows from finance leases $ (201) $ (197)
Schedule of Supplemental Balance Sheet Information	Other information related to leases was as follows (in thousands, except as noted within): As of March 31, As of December 31, 2023 2022 Finance lease ROU asset (included within Lease right-of-use assets) $ 263 $ 461 Operating lease ROU asset (included within Lease right-of-use assets) $ 249 $ 284 Weighted average remaining lease term (in years): Finance leases 0.33 0.58 Operating leases 1.55 0.42 Weighted average discount rate: Finance leases 2.50 % 2.50 % Operating leases 7.30 % 5.30 %
Schedule of Finance Lease Maturity	Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands): Finance leases Operating leases For the year ending: Remainder of 2023 $ 272 $ 175 2024 — 56 2025 — 58 2026 — — 2027 — — Thereafter — — Total future lease payments 272 289 Less: imputed interest (1) (22) Less: lease liabilities, current (271) (172) Lease liabilities, non-current $ — $ (95)
Schedule of Operating Lease Maturity	Maturities of lease liabilities as of March 31, 2023 were as follows (in thousands): Finance leases Operating leases For the year ending: Remainder of 2023 $ 272 $ 175 2024 — 56 2025 — 58 2026 — — 2027 — — Thereafter — — Total future lease payments 272 289 Less: imputed interest (1) (22) Less: lease liabilities, current (271) (172) Lease liabilities, non-current $ — $ (95)
Schedule of Principal Payments on all Long-term Debt	Future aggregate annual principal payments on long-term debt as of March 31, 2023 is expected to be as follows (in thousands): For the year ending: Remainder of 2023 $ 447 2024 715 2025 1,397 2026 42,355 2027 176 Thereafter 7,015 Total principal payments 52,105 Less: unamortized original issue discount and debt issuance costs (258) Less: current portion, net of unamortized original issue discount and debt issuance costs (550) Long-term debt, net of unamortized original issue discount and debt issuance costs $ 51,297

STOCK INCENTIVE PLANS (Tables)

STOCK INCENTIVE PLANS (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of RSU Rollforward	During the three months ended March 31, 2023, RSU activity for Service Providers and non-employee directors was as follows: Class A Common Stock LT50 Common Stock Weighted average grant date fair value per share Outstanding at December 31, 2022 3,379,657 3,304,643 $ 33.88 RSUs vested (123,549) (119,890) $ 33.35 RSUs cancelled/forfeited/expired (53,253) (53,253) $ 40.91 Outstanding at March 31, 2023 3,202,855 3,131,500 $ 33.88
Schedule of Stock Option Roll-forward	A summary of the Company's stock option activity was as follows: Shares Weighted average exercise price per share Weighted average Outstanding at December 31, 2022 6,301,650 $ 1.67 5.20 Options exercised (50,994) $ 1.28 Options cancelled/forfeited/expired (29,295) $ 2.69 Outstanding at March 31, 2023 6,221,361 $ 1.67 4.92 Exercisable at March 31, 2023 6,071,111 $ 1.50 4.88
Schedule of Stock-based Compensation Expense	The following table summarizes the stock-based compensation expense recognized for options granted under the 2009 Stock Plan, options and RSUs granted under the 2019 Stock Plan, RSUs granted under the 2021 Plan and matching shares issued under the Matching Plan (in thousands): Three Months Ended March 31, 2023 2022 Stock options $ 900 $ 1,006 Matching shares 249 2 Restricted stock units 9,512 13,659 Stock-based compensation $ 10,661 $ 14,667 Stock-based compensation expense is allocated based on the cost center to which the award holder spent time during the reported periods. Stock-based compensation expense is included in the following components of expenses on the accompanying Condensed Consolidated Statements of Operations (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue, net $ 3,306 $ 4,908 Research and development 2,206 2,708 General and administrative 2,644 4,975 Sales and marketing 1,848 2,076 Stock-based compensation expense $ 10,004 $ 14,667

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended March 31, 2023 2022 Numerator Net loss, basic and diluted $ (5,945) $ (7,376) Denominator Weighted average shares of common stock used to compute net loss per share, basic and diluted 81,768,429 80,147,208 Net loss per share, basic and diluted $ (0.07) $ (0.09)
Schedule of Anti-dilutive Securities	The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: Three Months Ended March 31, 2023 2022 Weighted average stock options 4,329,958 6,067,912 Matching shares 7,678 39,756 Total 4,337,636 6,107,668

REVENUE AND CERTAIN STATEMENT_3

REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS - Total Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue
Revenue	$ 40,101	$ 40,370
United States
Disaggregation of Revenue
Revenue	36,635	36,518
All other locations
Disaggregation of Revenue
Revenue	$ 3,466	$ 3,852

REVENUE AND CERTAIN STATEMENT_4

REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS - Narratives (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue
Consideration from a vendor, net	$ 2.1	$ 1.1
Cashback rewards
Disaggregation of Revenue
Cashback rewards	$ 1.2	$ 0.5

CERTAIN BALANCE SHEET COMPONE_3

CERTAIN BALANCE SHEET COMPONENTS - Other current assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Schedule Of Other Current Assets
Expensify Card posted collateral for funds held for customers	$ 8,645	$ 11,509
Cash in transit for funds held for customers	4,603	2,361
Income tax receivable	2,124	2,471
Matching Plan escrow and other restricted cash	29	52
Other	145	204
Other current assets	21,282	22,217
Expensify Payment LLC | Affiliated Entity
Schedule Of Other Current Assets
Restricted cash	100	102
Subsidiaries | Expensify.Org
Schedule Of Other Current Assets
Restricted cash	$ 5,636	$ 5,518

CERTAIN BALANCE SHEET COMPONE_4

CERTAIN BALANCE SHEET COMPONENTS - Capitalized software, net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized software development costs	$ 15,349	$ 14,052
Less: accumulated amortization	(7,768)	(7,171)
Capitalized software, net	$ 7,581	$ 6,881

CERTAIN BALANCE SHEET COMPONE_5

CERTAIN BALANCE SHEET COMPONENTS - Narratives (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Amortization expense	$ 0.7	$ 0.7
Depreciation	$ 0.5	$ 0.5

CERTAIN BALANCE SHEET COMPONE_6

CERTAIN BALANCE SHEET COMPONENTS - Property and equipment, net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment
Total property and equipment	$ 22,046	$ 22,019
Less: accumulated depreciation	(8,025)	(7,527)
Property and equipment, net	14,021	14,492
Computers and equipment
Property, Plant and Equipment
Total property and equipment	178	178
Furniture and fixtures
Property, Plant and Equipment
Total property and equipment	1,716	1,698
Leasehold improvements
Property, Plant and Equipment
Total property and equipment	6,957	6,948
Commercial building
Property, Plant and Equipment
Total property and equipment	6,493	6,493
Land
Property, Plant and Equipment
Total property and equipment	4,151	4,151
Construction in progress
Property, Plant and Equipment
Total property and equipment	$ 2,551	$ 2,551

CERTAIN BALANCE SHEET COMPONE_7

CERTAIN BALANCE SHEET COMPONENTS - Accrued expenses and other liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Sales, payroll and other taxes payable	$ 3,521	$ 2,721
Professional fees	1,936	1,473
Interest payable	1,407	1,318
Restricted common stock liability for early stock option exercises	1,067	1,283
Partner payouts and advertising fees	809	669
Cashback rewards	586	223
Accrued expense reports	264	291
Matching Plan payroll liability	192	195
Credit card processing fees	170	22
Hosting and license fees	84	75
Other	734	800
Accrued expenses and other liabilities	$ 10,770	$ 9,070

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Narratives (Details)	3 Months Ended
	Mar. 31, 2023 agreement
Commitments and Contingencies Disclosure [Abstract]
Number of operating leases agreements	2
Number of operating leases agreements not yet commenced	1

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Summary of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Finance lease cost:
Amortization of ROU assets	$ 198	$ 198
Interest on lease liabilities	3	7
Total finance lease cost	201	205
Operating lease cost	186	185
Total lease cost	$ 387	$ 390

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES - Summary of Related to Leases (Details)(Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Finance lease ROU asset (included within Lease right-of-use assets)	$ 263	$ 461
Operating lease ROU asset (included within Lease right-of-use assets)	$ 249	$ 284
Weighted average remaining lease term (in years):
Finance leases	3 months 29 days	6 months 29 days
Operating leases	1 year 6 months 18 days	5 months 1 day
Weighted average discount rate:
Finance leases	2.50%	2.50%
Operating leases	7.30%	5.30%
Finance Lease, Right-of-Use Asset, Statement of Financial Position	Lease right-of-use assets	Lease right-of-use assets
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Lease right-of-use assets	Lease right-of-use assets

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES - Cashflow Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ (210)	$ (192)
Operating cash flows from finance leases	(3)	(7)
Financing cash flows from finance leases	$ (201)	$ (197)

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES - Lease Maturity Schedule (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Finance leases
Remainder of 2023	$ 272
2024	0
2025	0
2026	0
2027	0
Thereafter	0
Total future lease payments	272
Less: imputed interest	(1)
Less: lease liabilities, current	(271)
Lease liabilities, non-current	$ 0
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Lease Liability, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Lease liabilities, non-current
Operating leases
Remainder of 2023	$ 175
2024	56
2025	58
2026	0
2027	0
Thereafter	0
Total future lease payments	289
Less: imputed interest	(22)
Less: lease liabilities, current	(172)
Lease liabilities, non-current	$ (95)
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Lease liabilities, current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Lease liabilities, non-current

COMMITMENTS AND CONTINGENCIES_6

COMMITMENTS AND CONTINGENCIES - Lease Maturity Narratives (Details) - USD ($) $ in Thousands	Apr. 20, 2023	Mar. 31, 2023
Lessee, Lease, Description
Total future lease payments		$ 289
Scenario, Plan | Leases Not Yet Commenced
Lessee, Lease, Description
Total future lease payments		$ 2,600
Subsequent Event | San Francisco Office
Lessee, Lease, Description
Total future lease payments	$ 6,900
Operating lease term of contract (in years)	11 years

COMMITMENTS AND CONTINGENCIES_7

COMMITMENTS AND CONTINGENCIES - Amortizing Term Mortgage (Details) - USD ($) $ in Thousands	1 Months Ended
	Aug. 31, 2019	Mar. 31, 2023	Dec. 31, 2022
Schedule of Capitalization, Long-term Debt
Long-term debt, net of original issue discount and debt issuance costs		$ 51,297	$ 51,434
Mortgages
Schedule of Capitalization, Long-term Debt
Loaned amount	$ 8,300
Debt instrument, term (in years)	30 years
Interest rate (as a percent)	5%
Long-term debt, net of original issue discount and debt issuance costs		$ 7,800	$ 7,800
Mortgages | Prime Rate
Schedule of Capitalization, Long-term Debt
Variable rate (as a percent)	0.25%

COMMITMENTS AND CONTINGENCIES_8

COMMITMENTS AND CONTINGENCIES - 2021 Amended Term Loan (Details) - USD ($)					1 Months Ended	3 Months Ended
	Oct. 01, 2025	Oct. 01, 2024	Sep. 30, 2024	Sep. 30, 2021	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Schedule of Capitalization, Long-term Debt
Repayments of long term debt						$ 150,000	$ 146,000
Long-term debt, net of original issue discount and debt issuance costs						$ 51,297,000		$ 51,434,000
2021 Amended Term Loan | Secured Debt
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 75,000,000	$ 75,000,000
Effective interest rate (as a percent)						10.25%
Long-term debt, net of original issue discount and debt issuance costs						$ 44,300,000		$ 44,500,000
2021 Amended Term Loan | Secured Debt | Reference Rate
Schedule of Capitalization, Long-term Debt
Variable rate (as a percent)				2.25%
2021 Amended Term Loan | Secured Debt | Forecast | Subsequent Event
Schedule of Capitalization, Long-term Debt
Periodic payment	$ 600,000	$ 200,000	$ 100,000
2021 Amended Term Loan | Line of Credit | Revolving Credit Facility
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 25,000,000	25,000,000	$ 25,000,000
Repayments of long term debt					23,500,000
2021 Amended Term Loan | Line of Credit | Revolving Credit Facility | Reference Rate
Schedule of Capitalization, Long-term Debt
Variable rate (as a percent)						1%
Effective interest rate (as a percent)						9%
Initial Term Loan | Secured Debt
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				45,000,000	$ 45,000,000
Debt instrument, term (in years)					60 months
Delayed Term Loan | Secured Debt
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 30,000,000	$ 30,000,000

COMMITMENTS AND CONTINGENCIES_9

COMMITMENTS AND CONTINGENCIES - Monthly revolving line of credit (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2021
Line of Credit Facility
Borrowings under line of credit	$ 15,000,000	$ 15,000,000
Unamortized debt issuance cost	258,000	300,000
2021 Amended Term Loan
Line of Credit Facility
Debt issuance cost	0
Issuance discount	0
Revolving Credit Facility | 2021 Amended Term Loan | Line of Credit
Line of Credit Facility
Maximum borrowing capacity	25,000,000		$ 25,000,000
Borrowings under line of credit	15,000,000	15,000,000
Remaining borrowing capacity	$ 10,000,000	$ 10,000,000
Revolving Credit Facility | 2021 Amended Term Loan | Line of Credit | Reference Rate
Line of Credit Facility
Variable rate (as a percent)	1%
Effective interest rate (as a percent)	9%

COMMITMENTS AND CONTINGENCIE_10

COMMITMENTS AND CONTINGENCIES - Future aggregate annual principal payments on all long-term debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Long-term Debt, Fiscal Year Maturity
Remainder of 2023	$ 447
2024	715
2025	1,397
2026	42,355
2027	176
Thereafter	7,015
Total principal payments	52,105
Less: unamortized original issue discount and debt issuance costs	(258)	$ (300)
Less: current portion, net of unamortized original issue discount and debt issuance costs	(550)	(551)
Long-term debt, net of unamortized original issue discount and debt issuance costs	$ 51,297	$ 51,434

COMMITMENTS AND CONTINGENCIE_11

COMMITMENTS AND CONTINGENCIES - Defined Contribution Plans (Details) - United States - USD ($)		3 Months Ended
	Jan. 01, 2018	Mar. 31, 2023	Mar. 31, 2022
Defined Contribution Plan
Employer discretionary matching		$ 0	$ 0
Employer contributions		$ 300,000	$ 200,000
Maximum
Defined Contribution Plan
Employer contribution (as a percent) (up to)	4.50%

STOCK INCENTIVE PLANS - 2009 an

STOCK INCENTIVE PLANS - 2009 and 2019 Stock Option Plan (Details) - shares	1 Months Ended
	Apr. 30, 2019	Jan. 31, 2018	Nov. 09, 2021	Sep. 30, 2021	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)	25,204,250
The 2009 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)		17,030,280			16,495,150
Additional shares authorized (in shares)		535,130
The 2019 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Additional shares authorized (in shares)	8,173,970
The 2019 Option Plan | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)			16,856,770	4,339,690
The 2019 Option Plan | Common Stock, LT50
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)			16,856,770
The 2019 Option Plan | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)				8,679,380
The 2019 Option Plan | Restricted stock units | Common Stock, LT50
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)				4,339,690

STOCK INCENTIVE PLANS - 2021 In

STOCK INCENTIVE PLANS - 2021 Incentive Plan and Matching Plan (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Mar. 14, 2023	Mar. 31, 2023	Dec. 31, 2022	Jan. 01, 2022	Nov. 30, 2021
2021 Incentive Plan | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Shares reserved for future issuance (in shares)		22,282,735	17,336,973		11,676,932
2021 Incentive Plan | Common Class A | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Shares reserved for future issuance (in shares)					87,576,990
Annual increase in shares reserved for future issuance (as a percent)				6%
Matching shares | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares purchased (in shares)	147,319
Shares purchase price (usd per share)	$ 7.46
Cash proceeds	$ 1.1
Stock Purchase and Matching Plan
Share-based Compensation Arrangement by Share-based Payment Award
Employer share match rate (as a percent)		1.50%
Stock Purchase and Matching Plan | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)		16,098

STOCK INCENTIVE PLANS - RSU Nar

STOCK INCENTIVE PLANS - RSU Narratives (Details) - Restricted stock units - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (in years)	8 years
Share-based compensation expense not yet recognized	$ 190.4		$ 204.2
Share-based compensation not yet recognized, recognition period (in years)	6 years 10 days	6 years 2 months 23 days
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Vested (in shares)	123,549
Common Class A | 2021 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	0
Vested (in shares)	2,313

STOCK INCENTIVE PLANS - RSU Rol

STOCK INCENTIVE PLANS - RSU Rollforward (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Weighted average grant date fair value per share
Beginning balance (in dollars per share) | $ / shares	$ 33.88
Vested (in dollars per share) | $ / shares	33.35
Cancelled/forfeited/expired (in dollars per share) | $ / shares	40.91
Ending balance (in dollars per share) | $ / shares	$ 33.88
Restricted stock units | Common Class A
RSU Rollforward
Beginning balance (in shares)	3,379,657
Vested (in shares)	(123,549)
Cancelled/forfeited/expired (in shares)	(53,253)
Ending balance (in shares)	3,202,855
Restricted stock units | Common Stock, LT50
RSU Rollforward
Beginning balance (in shares)	3,304,643
Vested (in shares)	(119,890)
Cancelled/forfeited/expired (in shares)	(53,253)
Ending balance (in shares)	3,131,500

STOCK INCENTIVE PLANS - Stock O

STOCK INCENTIVE PLANS - Stock Option Narratives (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Intrinsic value of options exercised	$ 0.4	$ 5.2
Intrinsic value of options outstanding	41.3		$ 46
Proceeds from issuance of common stock on exercise of stock options	0.1	$ 0.3
Stock options
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation expense not yet recognized	$ 7.2		$ 8.1
Share-based compensation not yet recognized, recognition period (in years)	1 year 1 month 2 days		1 year 2 months 15 days
Stock options | Common stock
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	0	0
Stock options | The 2019 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (in years)	4 years
Stock options | The 2009 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (in years)	4 years
Stock options | Ten Percent Holder | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price as a percentage of common stock (as a percent)	110%
Stock options | Other Than Ten Percent Holder
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price as a percentage of common stock (as a percent)	100%
Stock options | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award
Shares subject to repurchase related to stock options early exercised and not yet vested (in shares)	697,275		813,311
Non Statutory Options
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price as a percentage of common stock (as a percent)	100%
Weighted average stock options | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award
Shares subject to repurchase related to stock options early exercised and not yet vested	$ 1.1		$ 1.3

STOCK INCENTIVE PLANS - Stock_2

STOCK INCENTIVE PLANS - Stock Option Roll-forward (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Shares
Beginning balance (in shares)	6,301,650
Options exercised (in shares)	(50,994)
Options cancelled/forfeited/expired (in shares)	(29,295)
Ending balance (in shares)	6,221,361	6,301,650
Options exercisable (in shares)	6,071,111
Weighted average exercise price per share
Beginning balance (in dollars per share)	$ 1.67
Options exercised (in dollars per share)	1.28
Options cancelled/forfeited/expired (in dollars per share)	2.69
Ending balance (in dollars per share)	1.67	$ 1.67
Options exercisable (in dollars per share)	$ 1.50
Weighted average remaining contractual life, options outstanding (in years)	4 years 11 months 1 day	5 years 2 months 12 days
Weighted average remaining contractual life, options exercisable (in years)	4 years 10 months 17 days

STOCK INCENTIVE PLANS - Stock-B

STOCK INCENTIVE PLANS - Stock-Based Compensation by Award Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expense
Stock-based compensation	$ 10,661	$ 14,667
Stock options
Share-based Payment Arrangement, Expense
Stock-based compensation	900	1,006
Matching shares
Share-based Payment Arrangement, Expense
Stock-based compensation	249	2
Restricted stock units
Share-based Payment Arrangement, Expense
Stock-based compensation	$ 9,512	$ 13,659

STOCK INCENTIVE PLANS - Stock_3

STOCK INCENTIVE PLANS - Stock-Based Compensation Income Statement Location (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expense
Stock-based compensation expense	$ 10,004	$ 14,667
Cost of revenue, net
Share-based Payment Arrangement, Expense
Stock-based compensation expense	3,306	4,908
Research and development
Share-based Payment Arrangement, Expense
Stock-based compensation expense	2,206	2,708
General and administrative
Share-based Payment Arrangement, Expense
Stock-based compensation expense	2,644	4,975
Sales and marketing
Share-based Payment Arrangement, Expense
Stock-based compensation expense	$ 1,848	$ 2,076

STOCK INCENTIVE PLANS - Stock_4

STOCK INCENTIVE PLANS - Stock-Based Compensation Narratives (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock-based compensation capitalized as software development costs	$ 657	$ 287

INCOME TAXES - (Details)

INCOME TAXES - (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ (1,825,000)	$ (1,632,000)
Effective income tax rate (in percent)	44.30%	28.40%
Accrual for uncertain tax positions	$ 1,300,000		$ 1,200,000
Income tax examination, penalties and interest expense	$ 0		$ 0

NET LOSS PER SHARE - Schedule o

NET LOSS PER SHARE - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator
Net loss, basic	$ (5,945)	$ (7,376)
Net loss, diluted	$ (5,945)	$ (7,376)
Denominator
Weighted-average shares of common stock used to compute net loss per share, basic (in shares)	81,768,429	80,147,208
Weighted-average shares of common stock used to compute net loss per share, diluted (in shares)	81,768,429	80,147,208
Net loss per share, basic (in dollars per share)	$ (0.07)	$ (0.09)
Net loss per share, diluted (in dollars per share)	$ (0.07)	$ (0.09)

NET LOSS PER SHARE - Narratives

NET LOSS PER SHARE - Narratives (Details)	3 Months Ended
	Mar. 31, 2023 vote shares
Common Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Voting right per share (vote)	1
Shares converted (in shares) | shares	1
Common Stock, LT10
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Voting right per share (vote)	10
Conversion of stock, notice period (in months)	10 months
Common Stock, LT50
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Voting right per share (vote)	50
Conversion of stock, notice period (in months)	50 months

NET LOSS PER SHARE - Anti-dilut

NET LOSS PER SHARE - Anti-dilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	4,337,636	6,107,668
Weighted average stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	4,329,958	6,067,912
Matching shares
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	7,678	39,756

EQUITY (Details)

EQUITY (Details) $ in Millions	May 10, 2022 USD ($)
2022 Share Repurchase Program | Class A common stock
Equity, Class of Treasury Stock [Line Items]
Shares authorized for repurchase	$ 50

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Expensify.Org | Affiliated Entity
Related Party Transaction
Payment of commitments to related party	$ 0.1	$ 0.9